Emo Capital, I-Omni partner to develop new compression wear clothing line

Emo Capital Corp. (OTCQB: NUVI) (the "Company") is pleased to announce that a memorandum of understanding (MOU) was signed with I-Omni Co. Ltd. of Seoul, South Korea (I-Omni). The MOU is part of an ongoing collaboration to roll out a domestic market distribution of a new line of customized compression wear. It outlines additional terms between the two parties specific to the joint effort to develop a new compression wear clothing line, including sales and support channels in the U.S.

I-Omni partnered with Dong Seoul University to design a new line of custom fitted compression clothing wear that provides support that is particularly useful for people who have body support and or circulation issues. Currently an application for a method and apparatus patent for designing and fitting customized compression wear is being jointly made by I-Omni and Dong Seoul University.

Management commented, " A definitive contract with I-Omni will be next in the works which will solidify our strategy to deliver the highest quality compression wear technology."

The Company is focused on satisfying growing U.S. consumer demand as the compression wear market surpasses the one billion dollar mark in value. Consumers continue to show interest with further innovation and evolvement in compression wear garments. This agreement provides NUVI with another product to help deliver significant company growth by diversifying into other health style related products.

Source:

EMO CAPITAL CORP

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.